AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Total Debt History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Debt | ₹7,942 Cr | ₹6,315 Cr | ₹4,862 Cr | ₹2,373 Cr | ₹4,972 Cr |
What is the latest Total Debt ratio of AUROBINDO PHARMA ?
Year | Total Debt |
---|---|
Mar2025 | ₹7,942 Cr |
Mar2024 | ₹6,315 Cr |
Mar2023 | ₹4,862 Cr |
Mar2022 | ₹2,373 Cr |
Mar2021 | ₹4,972 Cr |
How is Total Debt of AUROBINDO PHARMA Trending?
Years | Total Debt | % Change | |
---|---|---|---|
Mar2025 | ₹7,942 Cr | 25.75 | |
Mar2024 | ₹6,315 Cr | 29.90 | |
Mar2023 | ₹4,862 Cr | 104.89 | |
Mar2022 | ₹2,373 Cr | -52.28 | |
Mar2021 | ₹4,972 Cr | - |
Compare Total Debt of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹60,638.4 Cr | 0.9% | -2.4% | -32.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,718.0 Cr | 1% | -0.2% | -13.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,282.0 Cr | -2.7% | -2.2% | 17.6% | Stock Analytics | |
CIPLA | ₹125,351.0 Cr | -1.7% | 4.1% | -5.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,267.0 Cr | 1% | 1.3% | 4.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,952.0 Cr | 2.5% | 7.7% | -6.7% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | 0.9% |
-2.4% |
-32.1% |
SENSEX | 1.2% |
0.7% |
-1.5% |
You may also like the below Video Courses